Leanbio is a cutting-edge CDMO specializing in recombinant proteins, antibodies, bioconjugates, and mRNA. With both microbial and mammalian production platforms, the company delivers seamless, end-to-end biopharmaceutical development and manufacturing services.

With over a decade of expertise, we have a proven track record in the development and manufacturing of therapeutic molecules such as antibodies, Fab fragments, ADCs, enzymes, complex proteins, mRNA, and pDNA. Leanbio has already worked with over 100 candidates over these years, some already in late clinical stages.

The manufacturing capabilities include over 4,000 sqm. with separate manufacturing areas: one for mammalian expression systems up to 2000L, another for microbial and yeast up to 1000L, and additional areas for ADCs (including cytotoxic management) and mRNA up to 50L. The facility includes state-of-the-art development laboratories, outstanding GMP Quality control rooms and a warehouse.

Leanbio is a global service provider for the development and manufacturing of biologics. Our commitment to excellence is evident in everything we do:

 The services offered include:

Biologics

2

OEB 1-3

Europe

EMA (Europe)